Although the polymerase chain reaction (PCR) identifies the culprit pathogen in central nervous system infections, 1 and in infective endocarditis (IE), 2 it did not feature, even as an adjunct, in the work-up of patients recently reported with fever of unknown origin, in whom blood-stream infections were only identified by blood culture (BC). 3 In the tertiary centre, where PCR was included in the evaluation of the cerebrospinal fluid (CSF), a commercially available multiplex PCR system generated a detection rate of 42.18% and clinical specificity of 100%. BC is hampered by diagnostic delay, low positivity rate (amounting to approximately one third in patients with sepsis) and false negative results due to previous antibiotic use. 4 Septifast, the most widely used PCR for blood-stream infections, can detect 9 gram positive cocci, 10 gram negative bacteria and 6 fungal species. A recent review also showed that 'the impact of [previous] 
in the work-up of patients recently reported with fever of unknown origin, in whom blood-stream infections were only identified by blood culture (BC). 3 In the tertiary centre, where PCR was included in the evaluation of the cerebrospinal fluid (CSF), a commercially available multiplex PCR system generated a detection rate of 42.18% and clinical specificity of 100%. 1 The detection rate amounted to 10 times higher than conventional tests. 1 In suspected IE, among 53 patients with simultaneous BC and PCR of a blood sample, BCs and PCR were positive in 52.8% and 64.2% of patients, respectively. 2 Positive PCR results for cocci and fungi were obtained in 10 of the 25 examinees with negative BCs. BC is hampered by diagnostic delay, low positivity rate (amounting to approximately one third in patients with sepsis) and false negative results due to previous antibiotic use. 4 Septifast, the most widely used PCR for blood-stream infections, can detect 9 gram positive cocci, 10 gram negative bacteria and 6 fungal species. A recent review also showed that 'the impact of [previous] antibiotic administration in BCs is a major problem solved by Septifast.' 4 Furthermore, in immunocompromised patients, PCR is significantly (P ¼ 0.0339) superior to BCs in detecting polymicrobial infections. 4 PCR also has a role in m tuberculosis bacteremia, either in the evaluation of a blood sample or in the evaluation of a urine sample. In the latter context, adjunctive evaluation of urine lipoarabinominnan (derived from the m tuberculosis cell wall) generates timely identification of 88% of HIV-positive subjects with positive m tuberculosis blood cultures.
